---
figid: PMC5240041__gr3
figlink: /pmc/articles/PMC5240041/figure/fig3/
number: Figure 3
caption: Intracellular signaling pathways in lymphangiogenesis. Signaling via VEGF-C/D
  and VEGFR-3 is the most well-known pathway for lymphangiogenesis. VEGF-C or VEGF-D
  binds to its receptor VEGFR-3 in the plasma membrane of LyECs, which facilitates
  signal transduction through various intracellular signaling pathways, leading to
  lymphangiogenesis. In the liver, activated macrophages in chronic inflammatory conditions,
  such as chronic hepatitis and liver cirrhosis, secrete VEGF-C and/or VEGF-D. Malignant
  liver tumors, such as HCC and intrahepatic cholangiocarcinoma, also secrete VEGF-C
  and/or VEGF-D. Furthermore, these malignant tumors activate tumor-associated macrophages,
  which also secrete VEGF-C and/or VEGF-D. Secreted VEGF-C and VEGF-D are likely related
  to lymphangiogenesis in liver diseases through VEGFR-3–mediated pathways.
pmcid: PMC5240041
papertitle: 'The Hepatic Lymphatic Vascular System: Structure, Function, Markers,
  and Lymphangiogenesis.'
reftext: Masatake Tanaka, et al. Cell Mol Gastroenterol Hepatol. 2016 Nov;2(6):733-749.
pmc_ranked_result_index: '66762'
pathway_score: 0.9205264
filename: gr3.jpg
figtitle: Intracellular signaling pathways in lymphangiogenesis
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5240041__gr3.html
  '@type': Dataset
  description: Intracellular signaling pathways in lymphangiogenesis. Signaling via
    VEGF-C/D and VEGFR-3 is the most well-known pathway for lymphangiogenesis. VEGF-C
    or VEGF-D binds to its receptor VEGFR-3 in the plasma membrane of LyECs, which
    facilitates signal transduction through various intracellular signaling pathways,
    leading to lymphangiogenesis. In the liver, activated macrophages in chronic inflammatory
    conditions, such as chronic hepatitis and liver cirrhosis, secrete VEGF-C and/or
    VEGF-D. Malignant liver tumors, such as HCC and intrahepatic cholangiocarcinoma,
    also secrete VEGF-C and/or VEGF-D. Furthermore, these malignant tumors activate
    tumor-associated macrophages, which also secrete VEGF-C and/or VEGF-D. Secreted
    VEGF-C and VEGF-D are likely related to lymphangiogenesis in liver diseases through
    VEGFR-3–mediated pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - VEGFC
  - HRAS
  - FLT4
  - MTOR
  - NRAS
  - MAPK1
  - KRAS
  - AKT1
  - AKT2
  - BRAF
  - PIK3R4
  - AKT3
  - RAF1
  - MAPK3
  - PIK3R6
  - PIK3R5
  - MAP2K1
  - ARAF
  - PIK3CG
  - MAP2K2
  - PIK3R3
  - PIK3CD
  - PIK3CB
  - RAC1
  - PIK3CA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: VEGF-D
  symbol: VEGF-D
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF-C
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: VEGFR-3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
